The Wildlife Technology Fund at Renaissance Philanthropy is an umbrella fund supporting coordinated research programs (CRPs) in the wild animal welfare space. We target interventions and bottlenecks.
The Fund is brand new, so our track record is just getting established. But our plan is to do rapid strategic research (where needed) or draw on existing strategic research to identify problems that fit our profile, work with talented program managers to coordinate and direct the needed research, and have implementation partners lined up for each program to ensure that someone carries forward the work to actually impacting animals at the end of the program. Where we can, we also prioritize programs that benefit people or the environment alongside animals. This increases the likelihood of programs being beneficial across a range of worldviews, and opens up additional sources of funding, sometimes improving the counterfactual cost-effectiveness of our activities.
Across animal welfare advocacy, the bottleneck is science. It takes science to validate that an agricultural practice is actually good for welfare, that it can be done in commercial conditions, and that the tools you’ve built actually work once they’re in place. It takes science to develop alternative proteins, to test whether people will eat them, and to find out how to bring down their cost. It takes science to establish whether a wild animal welfare intervention will meaningfully alter the ecosystem, and whether those changes will help animals on net. It takes science to create the tools and metrics we use to assess progress and make cost-effectiveness comparisons.
But getting that science done isn’t easy. One challenge is talent: the community hasn’t been recruiting scientists for very long, and has mostly relied on funding university researchers to take on projects for us. Traditional grant-making is often a great fit for early-stage research, where the goal is to explore open questions and follow promising leads. It’s a tougher fit for intervention-focused or goal-driven research, where we need a specific answer on a specific timeline. There are notable exceptions, but universities can be slow and bureaucratic. In many of the most relevant fields, academic incentives reward work that’s novel and interesting. That’s good for advancing a field, but it can pull a project toward an adjacent question partway through, even with a detailed contract in place. And as in every discipline, the very best scientists are rare, and standard grant processes don’t make it easy to find them. When research misses the mark, the cost goes beyond lost time, since it can send us in the wrong direction or create false confidence.
The Wildlife Technology Fund exists to do science for animal welfare faster and with a clearer focus on outcomes. We’re also working to bring more technical talent into the field. We run CRPs instead of traditional grants because evidence from other fields where they’ve been used suggests they encourage speed, keep work aligned with target outcomes, and suit complex, interdisciplinary problems like the ones we face.
Safer Landscapes is our program that is farthest along in development. It focuses on developing more humane approaches to managing rodent populations. Rodenticides kill (I estimate) billions of rodents annually, and plausibly tens of billions in years with major mouse or vole outbreaks. Rodenticide deaths also seem to be particularly bad, with some products causing days of disabling suffering (although studies of this are relatively sparse, making exact estimates challenging). Rodenticides also harm off-target wildlife, since they are sometimes consumed by other animals, and in the case of anticoagulant rodenticides, linger in the bodies of rats and kill or harm the animals that eat them. This program seeks to develop either a highly humane lethal control tool or a fertility control product that could disrupt rodenticide use. Our goal is to have handed off a basically-ready product to a commercial partner within 5 years, so they can take it forward through regulatory approvals.
The first stage of research for this program involves developing the specifications a product would need to meet to be effective and get people to actually use it (essentially a target product profile). Our estimates suggest that, depending on how it is implemented, this intervention could pass a 75 suffering-adjusted days per dollar benchmark even when the high cost of the product development research is included (we used similar suffering exchange-rates to ACE for comparability, and this benchmark is comparable with ACE top charities --- note, though, that our uncertainty ranges are very wide, in part because there are many potential intervention approaches, and many research gaps for relevant inputs. I expect these ranges to narrow as the leading candidate products are identified).
A nice feature of this program is that better rodent control has potential commercial value and also has benefits for global health and development outcomes. Rodents cause significant crop losses in LMICs, especially in tropical regions. Rodenticides can’t fully solve the problem because of compensatory reproduction and immigration, so despite widespread rodenticide use these problems persist. A product that is safer to distribute at larger scales could partially counteract these forces, leading to benefits for both people and wildlife. As a result, I believe that animal welfare funding for this program could catalyze additional investments from other funding spaces (and, with partners at Conservation X Labs, I am currently having conversations with funders in these communities).
Other program areas are in very early stages of scoping. They include:
Intervention-focused:
Bottleneck-focused:
The Fund launched in October 2026. It also draws on work I did as a fellow in Renaissance Philanthropy’s Big if True Science Accelerator (BiTS), starting from March 2026.
Over this period I have:
We need about $350k to fill our planned expenses for 2027. Activities planned for next year include:
The reason a search process could be particularly valuable: a huge number of medical products (for humans or animals) are tested first in rats. We’ve already found examples where a product developed for commercial use in, say, horses, has shown efficacy in rodents. Often these products and data are in the hands of commercial entities, and so not easily findable with a literature search. And these entities often don’t know anyone is looking for a rat fertility control or don’t think this direction would be profitable or they’re just focused on other things, so they just note fertility effects and move on. I believe that there could be valuable directions that are actually farther along in terms of product development that just aren’t easily accessible; running a highly publicized outreach process could help us surface those and decrease our timeline to impact.
Stretch goal
In terms of additional, potential activities: there are 3-5 grants I’d like to make which, together, would cost about $2.5M additional. These include:
Maximum scenario
As a further exploration of potential expenditures: It is possible I will discover additional fertility control candidates that are worth funding over the course of the year. If our program managers’ programs are scoped successfully, I predict they could make around $3M ($1M each) in grants to support scientific research (see the program list above, although program managers might also bring their own ideas).
Therefore, my projected max spend in 2027 (beyond funds already secured) is about $5.85M, although if we find additional promising grants it could of course be higher.
Interested donors can give via our website (bottom of page, here). For large gifts (e.g., $5000+) I recommend contacting me directly.